Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C420062 |
1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea |
1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea binds to and results in decreased activity of HCRTR1 protein | affects binding|decreases activity | 11459658
|
C420062 |
1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea |
1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea binds to and results in decreased activity of HCRTR1 protein | affects binding|decreases activity | 17638707
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HCRTR1 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of HCRTR1 mRNA | decreases expression | 15761015
|
C062876 |
cetrorelix |
cetrorelix results in decreased expression of HCRTR1 mRNA | decreases expression | 17638707
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of HCRTR1 mRNA | decreases expression | 16404146
|
D010424 |
Pentobarbital |
Pentobarbital results in decreased expression of HCRTR1 mRNA | decreases expression | 17638707
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HCRTR1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.95 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.42 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.76 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.76 | 17418594 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.88 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.87 | 21441931 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
4.95 | 18313124 11141031 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
9.96 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.96 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.14 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.07 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.59 | 15939500 15692762 18628466 16595493 16096432 16322301 15136595 15994142 19526202 16115903 18695136 15668708 17426702 15993339 16264153 16935488 15567936 15634643 18234424 18382427 17369602 11325840 17983394 16826403 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.63 | 11589617 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.25 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.31 | 15073043 16217749 11135700 14691202 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.31 | 18059187 16023760 16234567 17876044 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.32 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.27 | 1485588 16201981 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.38 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.70 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.70 | 16269455 16612575 17351982 17974986 15476868 16952015 17131338 16242529 16109756 16278810 17308081 15811867 17329180 17382496 16364871 16455267 18627295 17924179 16731534 15792986 15505089 17928571 17519947 17007740 16651473 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.02 | 16243910 17334414 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.03 | 19176532 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.65 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.65 | 18802399 18259882 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.51 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
1.89 | 10525206 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.40 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.53 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.50 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.87 | 18602426 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.76 | 12083418 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.62 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.60 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.36 | 12903497 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
8.67 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.67 | 20131406 19236843 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.98 | 19069698 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.59 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.52 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.70 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.67 | 14766674 16244371 16244372 16144979 16879835 18674790 17875725 16707910 16495754 12587719 18006777 17888722 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.58 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.58 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.18 | 15692506 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.35 | 16221962 19772884 19176532 18467677 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.65 | 18501091 17606976 15147373 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.45 | 20558911 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.80 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.20 | 15369732 15699352 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.44 | 16707910 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.95 | 15070760 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.60 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.08 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.70 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.63 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
4.04 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.17 | 16467208 16968895 20471514 19850784 17050201 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.38 | 16891316 16966277 15213294 15622746 11468182 17869043 17649720 19225113 17107899 16330433 12712474 11161223 17712046 12018890 19035177 12679006 19642359 17217047 16823087 15748426 9834237 15336539 19075265 16331271 16112521 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.68 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.54 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.54 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
4.77 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.77 | 20007298 16377806 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.68 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.68 | 16842330 17085340 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.56 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
2.69 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.69 | 6189445 17418594 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.65 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.02 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.93 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.19 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.32 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.15 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.78 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.19 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.29 | 14977855 19417148 19549372 11468182 15949261 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.86 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
5.12 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.28 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.04 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.04 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.16 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.29 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.04 | 18259882 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.06 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.13 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.25 | 16889571 15640375 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.28 | 10525206 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.39 | 15555623 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.34 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.47 | 19769630 12452020 16624393 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.60 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.47 | 19927285 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.60 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.60 | 17638057 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.33 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.33 | 16729912 16888761 15897917 15749863 18437689 16868541 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
6.42 | 10930210 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.58 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.50 | 19058328 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.25 | 17203757 16767912 17710206 15625365 18313854 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
11.40 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
11.40 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.19 | 17846226 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
4.07 | 9754883 10087439 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.06 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.93 | 17203757 15625365 16767912 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
5.24 | 9754883 11529278 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
8.04 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
8.04 | 16010429 17909728 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.36 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.56 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.56 | 17653716 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.58 | 17678736 16364871 17334414 17638931 |